Search Results

Influence of Some Cardiovascular Risk Factors on the Expression of Platelet Glycoprotein IIb/IIIa Receptors in Patients with Myocardial Infarction Treated with Antiplatelet Drugs under Primary Percutaneous Coronary Intervention

Authors: Konopka, Anna; Spychalska, Justyna; Piotrowski, Walerian; Stępińska, Janina

Source: Molecular Diagnosis & Therapy, Volume 13, Number 6, 1 December 2009 , pp. 375-382(8)

Publisher: Adis International

Potential Interaction between Clopidogrel and Proton Pump Inhibitors

Authors: Howard, Patricia A.; Vacek, James L.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 6, 1 December 2009 , pp. 353-359(7)

Publisher: Adis International

Platelet reactivity and nonresponse to dual antiplatelet therapy: A review

Authors: Vila, Peter M.; Zafar, M. Urooj; Badimon, Juan J.

Source: Platelets, Volume 20, Number 8, June 2009 , pp. 531-538(8)

Publisher: Informa Healthcare

Inhibition of platelet activation by peptide analogs of the β₃-intracellular domain of platelet integrin α_IIbβ₃ conjugated to the cell-penetrating peptide Tat(48-60)

Authors: Dimitriou, Andromaxi A.; Stathopoulos, Panagiotis; Mitsios, John V.; Sakarellos-Daitsiotis, Maria; Goudevenos, John; Tsikaris, Vassilios; Tselepis, Alexandros D.

Source: Platelets, Volume 20, Number 8, June 2009 , pp. 539-547(9)

Publisher: Informa Healthcare

eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment

Authors: Fatini, Cinzia; Sticchi, Elena; Bolli, Paola; Marcucci, Rossella; Giusti, Betti; Paniccia, Rita; Gori, Anna Maria; Gensini, Gian Franco; Abbate, Rosanna

Source: Platelets, Volume 20, Number 8, June 2009 , pp. 548-554(7)

Publisher: Informa Healthcare

Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era

Author: Rodriguez, Alfredo E

Source: Expert Opinion on Emerging Drugs, Volume 14, Number 4, December 2009 , pp. 561-576(16)

Publisher: Informa Healthcare

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations

Authors: Ellis, Kyle J; Stouffer, George A; McLeod, Howard L; Lee, Craig R

Source: Pharmacogenomics, Volume 10, Number 11, November 2009 , pp. 1799-1817(19)

Publisher: Future Medicine

ProFESS trial: any lessons to learn for future anti-platelet trials?

Authors: Sharma, J. C.; Vassallo, M.; Ross, I. N.

Source: International Journal of Stroke, Volume 4, Number 6, December 2009 , pp. 458-460(3)

Publisher: Blackwell Publishing

Antithrombotic therapy for heart failure in sinus rhythm

Authors: Subramaniam, Veeran; Davis, Russell C.; Shantsila, Eduard; Lip, Gregory Y.H.

Source: Fundamental & Clinical Pharmacology, Volume 23, Number 6, December 2009 , pp. 705-717(13)

Publisher: Blackwell Publishing

Antiplatelet Treatment in Ischemic Stroke Treatment

Authors: Pinto, Antonio; Di Raimondo, Domenico; Tuttolomondo, Antonino; Di Sciacca, Riccardo; Arnao, Valentina; Placa, Sergio L.; Milio, Glauco; Miceli, Salvatore; Licata, Giuseppe

Source: Current Topics in Medicinal Chemistry, Volume 9, Number 14, October 2009 , pp. 1298-1316(19)

Publisher: Bentham Science Publishers

Cangrelor: a review on its mechanism of action and clinical development

Authors: Ferreiro, José Luis; Ueno, Masafumi; Angiolillo, Dominick J

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 10, October 2009 , pp. 1195-1201(7)

Publisher: Expert Reviews

Efficacy of aspirin for secondary prevention in patients with peripheral artery disease

Authors: Feldman, Dmitriy N; Moussa, Issam D

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 10, October 2009 , pp. 1203-1207(5)

Publisher: Expert Reviews

Antithrombotic medication for stroke prevention

Authors: Weimar, Christian; Weber, Ralph; Diener, Hans-Christoph

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 10, October 2009 , pp. 1245-1254(10)

Publisher: Expert Reviews

A pilot randomized trial comparing an intensive versus a standard intervention in stable HIV-infected patients with moderatehigh cardiovascular risk

Authors: Masi, Mar; Bernal, Enrique; Padilla, Sergio; Garca, Natalia; Escribano, Jos C.; Martnez, Esteban; Gutirrez, Flix

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 3, 7 September 2009 , pp. 589-598(10)

Publisher: Oxford University Press

Time-related Histopathologic Changes in Fresh Frozen Carotid Xenografts in a Pig-to-Goat Implantation Model

Authors: Chang, Ji M.; Kim, Won G.

Source: Artificial Organs, Volume 33, Number 10, October 2009 , pp. 827-834(8)

Publisher: Blackwell Publishing

Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel

Authors: Nishiya, Y.; Hagihara, K.; Kurihara, A.; Okudaira, N.; Farid, N.A.; Okazaki, O.; Ikeda, T.

Source: Xenobiotica, Volume 39, Number 11, November 2009 , pp. 836-843(8)

Publisher: Informa Healthcare

Antiplatelet aggregation activity of compounds isolated from Guttiferae species in human whole blood

Authors: Jantan, Ibrahim; Mohd Yasin, Yusyila Harlina; Jalil, Juriyati; Murad, Shahnaz; Idris, Muhammad Sum

Source: Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Volume 47, Number 11, November 2009 , pp. 1090-1095(6)

Publisher: Informa Healthcare

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome

Authors: Gao, Xiu-ren; Adhikari, Chandar M.; Peng, Long-yun; Guo, Xiao-gang; Zhai, Yuan-sheng; He, Xu-yu; Zhang, Li-Yuan; Lin, Jun; Zuo, Zhi-yi

Source: Journal of Pharmacy and Pharmacology, Volume 61, Number 11, November 2009 , pp. 1505-1510(6)

Publisher: Pharmaceutical Press

Does Platelet Administration Affect Mortality in Elderly Head-Injured Patients Taking Antiplatelet Medications?

Authors: Downey, Douglas M.; Monson, Benjamin; Butler, Karyn L.; Fortuna, Gerald R.; Saxe, Jonathan M.; Dolan, James P.; Markert, Ronald J.; McCarthy, Mary C.

Source: The American Surgeon, Volume 75, Number 11, November 2009 , pp. 1100-1103(4)

Publisher: Southeastern Surgical Congress

Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR₁ and PAR₄ in platelets

Authors: Navarro-Núñez, L; Rivera, J; Guerrero, JA; Martínez, C; Vicente, V; Lozano, ML

Source: British Journal of Pharmacology, Volume 158, Number 6, November 2009 , pp. 1548-1556(9)

Publisher: Blackwell Publishing